Program & Downloads
Click here to download the entire book (786KB) –
To navigate in the pages, please use the search tool or the bookmarks.
Click here to see the speakers list
CONGRESS 2012
- Introduction : Hepatitis C : A big step towards eradication - Patrick MARCELLIN (France)
-
8:45 – 10:15
Triple therapy today. Phase III results in G1 naïve patients
Chairs :
Massimo COLOMBO (Italy) Michael MANNS (Germany)
- 8:45 Telaprevir - Ira JACOBSON (USA) Download
- 9:05 Boceprevir - Michael MANNS (Germany) Download
- 9:25 Safety management in clinical practicee - Christophe HEZODE (France) Download
- 9:55 Round table - All speakers
- 10:20 - 10:50 Coffee break
-
10:50 – 12:00
Triple therapy today. Phase III results in G1 relapsers and non responders
Chairs :
Geoffrey DUSHEIKO (UK) Eugene SCHIFF (USA)
- 10:50 Telaprevir - Stefan ZEUZEM (Germany) Download
- 11:10 Boceprevir - Bruce BACON (USA) Download
- 11:30 Round table - All speakers
-
12:00 – 12:30
State of the Art Lecture
Chairman:
Patrick MARCELLIN (France)
- The EASL HCV Clinical Practice Guidelines - Antonio CRAXI (Italy) Download
-
12:30 – 14:30 Interactive luncheons Room 1
French speaking luncheon : Comment optimiser le traitement des patients naifs
Chair: Patrice COUZIGOU (France)
Speakers:
Najet BELHADJ BRIK (Tunisia) Download
Denis OUZAN (France) Download
Rachid OULD GOUGAM (Algeria) Download
Room 7
Future therapies
Chair: Tarik ASSELAH (France)
Speakers:
Massimo LEVRERO (France) Download
Francesco NEGRO (Switzerland) Download
Mark SULKOWSKI (USA) Download
Room 8
Non invasive markers of fibrosis
Chair: Pierre BEDOSSA (France)
Speakers:
Victor DE LEDINGHEN (France) Download
Ana Carolina CARDOSO (Brazil) Download
Paul CALES (France) Download
-
14:30 – 15:30
What’s new in non G1 ?
Chairs :
Jia-Horng KAO (Taiwan) Alfredo ALBERTI (Italy)
- 14:30 Genotype 2 - Alessandra MANGIA (Italy) Download
- 14:45 Genotype 3 - Graham FOSTER (UK) Download
- 15:00 Genotype 4 - Gamal ESMAT (Egypt) Download
- 15:15 Round table - All speakers
- 15:30 - 16:00 Coffee break
-
16:00 – 17:00
Special Populations
Chairs :
Teerha PIRATVISUTH (Thailand) Sam LEE (Canada)
- 16:00 Cirrhotics - Marc BOURLIERE (France) Download
- 16:15 Pre and post liver transplantation - Didier SAMUEL (France) Download
- 16:30 HCV-HIV coinfection - Mark SULKOWSKI (USA) Download
- 16:45 Round table - All speakers
-
17:00
State of the Art Lecture
Chairman:
Patrick MARCELLIN (France)
- Introduction - Patrick MARCELLIN (France)
- The history of HCV therapy - Jay HOOFNAGLE (USA) Download
- 18:00 Ajournement
- 19:30 Congress Dinner
- Introduction - Patrick MARCELLIN (France)
-
8:45-10:15
Controversies Part 1
Chairs :
Jean-Pierre ZARSKI (France) Nezam AFDHAL (USA)
- 8:45 Telaprevir or Boceprevir ? - Mitchell SHIFFMAN (USA) Download
- 9:15 Lead in or no lead in ? Lawrence SERFATY (France) Download Graham FOSTER (UK) Download
- 9:45 Response unguided or guided ? Raj REDDY (USA) Download Fabien ZOULIM (France) Download
- 10:15 - 10:45 Coffee break
-
10:45-11:45
Controversies Part 2
Chairs :
Mark THURSZ (UK) Masao OMATA (Japan)
- 10:45 Do IL28B or not do IL28B ? Stanislas POL (France) Download Donald JENSEN (USA) Download
- 11:15 Resistance is important : Yes or No ? Christoph SARRAZIN (Germany) Download Philippe HALFON (France) Download
-
11:45
State of the Art Lecture
Chairman:
Tarik ASSELAH (France)
- Introduction : Is the game over ? - Raymond SCHINAZI (USA)
- New targets for antivirals against HCV - Ralf BARTENSCHLAGER (Germany)
-
12:30 – 14:30 Interactive Luncheons Room 1
French speaking luncheon : Comment optimiser la prise en charge des patients rechuteurs et non répondeurs
Chair: Christian TREPO (France)
Speakers:
Mustapha BENAZZOUZ (Morocco) Download
Mihai VOICULESCU (Romania) Download
Albert TRAN (France) Download
Room 2
How to optimize treatment of G1 patient ?
Chairs: Antonio CRAXI (Italy) Marina BERENGUER (Spain)
-
14:30 – 15:00
State of the Art Lecture
Chairman:
Tarik ASSELAH (France)
- How to improve access to therapy - Michael FRIED (USA) Download
-
15:00 - 16:15
The future
Chairs :
Jidong JIA (China) Jake LIANG (USA)
- 15:00 Advantages of new generation DAAs - Tarik ASSELAH (France) Download
- 15:20 Is Ribavirin still useful ? - David NELSON (USA) Download
- 15:40 Are interferons really necessary ? - Peter FERENCI (Austria) Download
- 16:45 Round table - All speakers
- 16:15 -16:30 Conclusion and perspectives - Patrick MARCELLIN (France) Download